Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fast Food Indonesia Tbk. (FAST) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Fast Food Indonesia Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Fast Food Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Fast Food Indonesia Tbk. trades at Rp276 (market cap 1.22T, 847.1K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 9.2× Fast Food Indonesia Tbk.'s market cap, and Fast Food Indonesia Tbk. is more actively traded (847.1K versus 613K). Which is the better fit depends on your goals.

FASTTSPC
Market Cap
1.22T11.18T
Volume
847.1K613K
Lot
8.47K6.13K
Turnover
227.75M1.54B
Average Price
268.862,511.52
Value
227.75M1.54B
Indicative Equilibrium Price
2762,520
Indicative Equilibrium Volume
1317

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FAST
View details
TSPC
View details

About Fast Food Indonesia Tbk.

PT. Fast Food Indonesia Tbk is a company founded in 1978 by the Gelael Group and the exclusive KFC franchise holder in Indonesia. The first KFC outlet opened in October 1979 at Jl. Melawai, Jakarta proved to be successful and paved the way for the opening of more additional outlets in Jakarta. The Company expanded its regional coverage to include other major cities in Indonesia and because of its success in building KFC brand image for the past 20 years of operation, KFC became the country’s dominant fast food market leader.

Read more on FAST

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC